- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- March 2026
- 121 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- September 2026
- 356 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 386 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 285 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 144 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 180 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 246 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- August 2026
- 125 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- May 2026
- 140 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- May 2026
- 400 Pages
Global
From €4506EUR$4,949USD£3,865GBP
- Report
- May 2026
- 400 Pages
Global
From €4506EUR$4,949USD£3,865GBP
- Report
- April 2026
- 136 Pages
Global
From €2731EUR$2,999USD£2,342GBP
€3641EUR$3,999USD£3,123GBP
- Report
- August 2026
- 158 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 130 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 131 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 120 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- May 2026
- 140 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- May 2026
- 140 Pages
Global
From €4325EUR$4,750USD£3,710GBP

The Real World Evidence (RWE) market within the context of E-Healthcare is a rapidly growing sector. It is a form of evidence-based medicine that uses data from real-world sources such as patient records, claims data, and observational studies to inform healthcare decisions. RWE can be used to assess the safety and effectiveness of treatments, identify new indications for existing treatments, and inform healthcare policy. It can also be used to assess the cost-effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
RWE is increasingly being used by healthcare providers, payers, and pharmaceutical companies to inform their decisions. It is also being used by researchers to gain insights into the effectiveness of treatments and to identify potential areas of improvement in healthcare delivery.
Some companies in the RWE market include IBM Watson Health, Optum, Flatiron Health, and Evidation Health. Show Less Read more